Skip to main content
. Author manuscript; available in PMC: 2010 May 14.
Published in final edited form as: Drug Test Anal. 2009 Sep;1(9-10):447–454. doi: 10.1002/dta.96

Table 2.

Study on volunteers treated with rhGH subcutaneous injections: Urinary hGH concentration [pg/mL]+/−STD / (number of volunteers), adapted from Saugy and colleagues.[19]

Before
treatment
[pg/mL] /
(#athletes)		 Day 1
[pg/mL] /
(#athletes)		 Day 2
[pg/mL] /
(#athletes)		 Day 3
[pg/mL] /
(#athletes)		 Day 4
[pg/mL] /
(#athletes)		 Day 5
[pg/mL] /
(#athletes)
non treated
non
exercising
volunteers 		4.2 / (196)
12 I.U.
subcutaneous
application 		4.3+/−4.1 /

(9)		 136+/−84 /

(9)		 185+/−

(83) / (9)		 147+/−67 /

(9)		 182+/−73 /

(9)		 202+/−121

/ (9)